Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.

about

Small-Molecule CD4-Mimics: Structure-Based Optimization of HIV-1 Entry Inhibition.

P2860

Q36681727-145F93FF-B89C-48E4-8AC9-04603EA46440

P2860

Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.

Item

http://www.wikidata.org/entity/Q38816992

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Synthesis, antiviral activity ...... olecule HIV-1 entry inhibitor.

@en

type

Item

label

Synthesis, antiviral activity ...... olecule HIV-1 entry inhibitor.

@en

altLabel

Synthesis, antiviral activity ...... molecule HIV-1 entry inhibitor

@en

prefLabel

Synthesis, antiviral activity ...... olecule HIV-1 entry inhibitor.

@en

P1476

Synthesis, antiviral activity ...... olecule HIV-1 entry inhibitor.

@en

P2093

Asim K Debnath

http://www.w3.org/2001/XMLSchema#string

Francesca Curreli

http://www.w3.org/2001/XMLSchema#string

Jinfeng Xu

http://www.w3.org/2001/XMLSchema#string

Kashfia Haque

http://www.w3.org/2001/XMLSchema#string

Lihua Xie

http://www.w3.org/2001/XMLSchema#string

Qian Qiu

http://www.w3.org/2001/XMLSchema#string

Weizhong Yong

http://www.w3.org/2001/XMLSchema#string

Xiaohe Tong

http://www.w3.org/2001/XMLSchema#string

P2860

Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity

Interfacial Cavity Filling To Optimize CD4–Mimetic Miniprotein Interactions with HIV-1 Surface Glycoprotein

Access denied? The status of co-receptor inhibition to counter HIV entry

An inducible cell-cell fusion system with integrated ability to measure the efficiency and specificity of HIV-1 entry inhibitors

Human immunodeficiency virus type 1 coreceptors participate in postentry stages in the virus replication cycle and function in simian immunodeficiency virus infection

Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype

Antibody neutralization and escape by HIV-1

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies

Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy.

P304

7618-7628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMC.2015.11.006

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26602829

http://www.w3.org/2001/XMLSchema#string

P921

drug discovery

molecular medicine

molecular biology

P932

4684972

http://www.w3.org/2001/XMLSchema#string

Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.

about

P2860

P2860

Synthesis, antiviral activity and resistance of a novel small molecule HIV-1 entry inhibitor.

description

name

type

label

altLabel

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932